Page 39 – ORTHOWORLD

Speed and Discipline: Enovis’ Roadmap to Growth

We spoke to Enovis CEO Matt Trerotola about M&A integration, enabling technologies and the company's strategy in the foot and...

Oct 24, 2024, Mike Evers

The expanded platform now features a complete femoral and acetabular portfolio to address various levels of surgical complexity....

Oct 22, 2024, Julie A. Vetalice

CEO of Spine, Rebecca Whitney, and Executive Chairman of the Board, Eric Major, share what we can expect from the...

Oct 21, 2024, Carolyn LaWell

Posted at 13:55h in Videos by Mike Evers

This video delves into the state of the sports medicine market, exploring the trends shaping its trajectory to over $8.5...

The CartRevive hydrogel implant is designed to enable optimal cartilage repair in the knee....

Oct 18, 2024, Julie A. Vetalice

At six months post-grafting surgery with NVDX3, x-rays demonstrate that 90% of patients have reached, or are steadily progressing towards,...

Oct 18, 2024, Julie A. Vetalice

The Phantom Fibula Nail is designed to give surgeons a less invasive option to treat the fibula when patients sustain...

Oct 17, 2024, Julie A. Vetalice

The company's orthopedic sales grew in the low single digits in the third quarter of 2024 on restructuring and APAC...

Oct 16, 2024, Mike Evers

InfectoSynovia is being developed to provide a high-accuracy bedside test that can diagnose periprosthetic joint infection in under five minutes....

Oct 16, 2024, Julie A. Vetalice

The Osteo Onyx roughened surface technology provides purchase within the pedicle that can benefit patients with osteoporosis or poor bone...

Oct 16, 2024, Julie A. Vetalice